Nanomedicine and Applications in Cancer : A Complete Guide to Nanomedicine and Cancer Applications (Drugs and the Pharmaceutical Sciences)

個数:

Nanomedicine and Applications in Cancer : A Complete Guide to Nanomedicine and Cancer Applications (Drugs and the Pharmaceutical Sciences)

  • 提携先の海外書籍取次会社に在庫がございます。通常3週間で発送いたします。
    重要ご説明事項
    1. 納期遅延や、ご入手不能となる場合が若干ございます。
    2. 複数冊ご注文の場合は、ご注文数量が揃ってからまとめて発送いたします。
    3. 美品のご指定は承りかねます。

    ●3Dセキュア導入とクレジットカードによるお支払いについて
  • 【入荷遅延について】
    世界情勢の影響により、海外からお取り寄せとなる洋書・洋古書の入荷が、表示している標準的な納期よりも遅延する場合がございます。
    おそれいりますが、あらかじめご了承くださいますようお願い申し上げます。
  • ◆画像の表紙や帯等は実物とは異なる場合があります。
  • ◆ウェブストアでの洋書販売価格は、弊社店舗等での販売価格とは異なります。
    また、洋書販売価格は、ご注文確定時点での日本円価格となります。
    ご注文確定後に、同じ洋書の販売価格が変動しても、それは反映されません。
  • 製本 Hardcover:ハードカバー版/ページ数 220 p.
  • 言語 ENG
  • 商品コード 9781032853741
  • DDC分類 615.19

Full Description

Nanomedicine represents a paradigm shift in cancer therapeutics, offering targeted drug delivery, reduced systemic toxicity, and enhanced efficacy. This book provides a detailed and systematic overview of nanomedicine formulations and their diverse applications across the cancer treatment landscape.

Beginning with fundamental principles of nanoparticle synthesis, characterization, and application in medicine, the text progresses to explore key nanoparticle platforms. Polymer-based nanoparticles are examined with respect to material properties, production methodologies, and their role in developing tailored cancer therapies. A dedicated section addresses lipid-based nanoparticles, focusing on the complexities of biological delivery, clinical successes, and essential considerations for stability and storage. Self-generating nanoemulsions (SGNEs) are introduced as a strategy to enhance drug bioavailability and overcome resistance, with attention given to regulatory pathways for clinical translation.

This book further elucidates site-specific drug delivery, detailing passive and active targeting mechanisms through various ligands. Diagnostic applications of nanomedicine are also presented, with a focus on fluorescent nanoparticles, their characterization, biomedical uses, clinical trial status, and limitations in comparison to alternative diagnostic modalities.

Critical areas such as cancer immunotherapy, including preventive and therapeutic vaccines and oncolytic viruses, and the burgeoning field of RNA-based therapeutics, highlighting the role of nanotechnology in their stabilization and targeted delivery, are thoroughly discussed. The text culminates with an overview of CAR-T cell therapy, associated challenges, innovative engineering strategies like CRISPR/Cas9, nanoparticle-mediated gene delivery, and relevant clinical advancements. Finally, this book addresses the multifaceted hurdles hindering the clinical translation of cancer-targeting nanomedicines, proposing potential solutions and design considerations to optimize clinical outcomes.

Key Features

In-Depth Coverage of Nanomedicine in Oncology: A comprehensive guide covering fundamental principles to advanced diagnostic and therapeutic strategies in cancer care.
Focus on Targeted Drug Delivery and Imaging: Highlights nanoparticle formulations (polymer, lipid, nano-emulsions) for precise drug delivery and advanced imaging techniques for early diagnosis.
Exploration of Cutting-Edge Therapeutic Modalities: Covers breakthroughs in nanoparticle-enhanced immunotherapy, RNA therapeutics, and nanotechnology's role in CAR-T cell therapy.
Clinical Translation Focus: Bridges research and clinical application, addressing challenges and opportunities in bringing nanomedicines to patients.

Contents

1. Introduction to Nanoparticles and Nanomedicine in Cancer Therapy 2. Polymer-based Nanoparticle Formulations for Targeted Drug Delivery. 3. Lipid Nanoparticles Formulations for Targeted Drug Delivery. 4. Self-Generating Nano-Emulsions for Enhanced Anticancer Delivery. 5. Active targeting of nanoparticles is a smart way for cancer. 6. Nanomedicine-based Imaging Techniques in Cancer Diagnosis. 7. Immunotherapy for Cancer. 8. RNA Therapeutics for Cancer. 9. Chimeric Antigen Receptor (CAR)-T cell Therapy: State of the Edge and the Recent Strategies Using CRISPR and mRNA. 10. Clinical Translation of Nanomedicines; Keys of Cancer Targeting.

最近チェックした商品